{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:01:29Z","timestamp":1788314489771,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:00:00Z","timestamp":1464912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Project 2012\/011"],"award-info":[{"award-number":["Project 2012\/011"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2014-55903-R"],"award-info":[{"award-number":["SAF2014-55903-R"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00213-016-4342-6","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T06:22:25Z","timestamp":1464934945000},"page":"2955-2971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD\/FADD ratio after chronic desipramine and fluoxetine administration"],"prefix":"10.1007","volume":"233","author":[{"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas A.","family":"Garc\u00eda-Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,3]]},"reference":[{"key":"4342_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2005.06.024","volume":"19","author":"EC Alappat","year":"2005","unstructured":"Alappat EC, Feig C, Boyerinas B, Vokland J, Samuels M, Murmann AE et al (2005) Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell 19:321\u2013332","journal-title":"Mol Cell"},{"key":"4342_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MJT.0b013e31825b9eb5","volume":"19","author":"SK Al-Nuaimi","year":"2012","unstructured":"Al-Nuaimi SK, Mackenzie EM, Baker GB (2012) Monoamine oxidase inhibitors and neuroprotection: a review. Am J Ther 19:436\u2013448","journal-title":"Am J Ther"},{"key":"4342_CR3","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.euroneuro.2015.07.019","volume":"25","author":"M \u00c1lvaro-Bartolom\u00e9","year":"2015","unstructured":"\u00c1lvaro-Bartolom\u00e9 M, Garc\u00eda-Sevilla JA (2015) The neuroplastic index p-FADD\/FADD and phosphoprotein PEA-15, interacting at GABAA receptor, are upregulated in brain cortex during midazolam-induced hypnosis in mice. Eur Neuropsychopharmacol 25:2131\u20132144","journal-title":"Eur Neuropsychopharmacol"},{"key":"4342_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.08.074","volume":"196","author":"M \u00c1lvaro-Bartolom\u00e9","year":"2011","unstructured":"\u00c1lvaro-Bartolom\u00e9 M, La Harpe R, Callado LF, Meana JJ, Garc\u00eda-Sevilla JA (2011) Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats. Neuroscience 196:1\u201315","journal-title":"Neuroscience"},{"key":"4342_CR5","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2174\/1871527313666141130224004","volume":"13","author":"N Antypa","year":"2014","unstructured":"Antypa N, Calati R, Serretti A (2014) The neuropsychological hypothesis of antidepressant drug action revisited. CNS Neurol Disord Drug Targ 13:1722\u20131739","journal-title":"CNS Neurol Disord Drug Targ"},{"key":"4342_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.euroneuro.2013.04.013","volume":"25","author":"F Artigas","year":"2015","unstructured":"Artigas F (2015) Developments in the field of antidepressants, where do we go now? Eur Neuropsychopharmacol 25:657\u2013670","journal-title":"Eur Neuropsychopharmacol"},{"key":"4342_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00406-011-0259-6","volume":"261","author":"TC Baghai","year":"2011","unstructured":"Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN et al (2011) General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 261:207\u2013245","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4342_CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-0327(91)90041-P","volume":"21","author":"GB Baker","year":"1991","unstructured":"Baker GB, Wong JT, Yeung JM, Coutts RT (1991) Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord 21:207\u2013211","journal-title":"J Affect Disord"},{"key":"4342_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55\u201368","journal-title":"N Engl J Med"},{"key":"4342_CR10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/cc.4.11.2188","volume":"4","author":"MS Bhojani","year":"2005","unstructured":"Bhojani MS, Chen G, Ross BD, Beer DG, Rehemtulla A (2005) Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer. Cell Cycle 4:1478\u20131481","journal-title":"Cell Cycle"},{"key":"4342_CR11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mp.2011.92","volume":"17","author":"A Bortolozzi","year":"2012","unstructured":"Bortolozzi A, Casta\u00f1\u00e9 A, Semakova J, Santana N, Alvarado G, Cort\u00e9s R et al (2012) Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Mol Psychiatry 17:612\u2013623","journal-title":"Mol Psychiatry"},{"key":"4342_CR12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1471-4159.1998.70031114.x","volume":"70","author":"LF Callado","year":"1998","unstructured":"Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, Garc\u00eda-Sevilla JA (1998) Selective increase of \u03b12A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 70:1114\u20131123","journal-title":"J Neurochem"},{"key":"4342_CR13","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/jm501690r","volume":"58","author":"S Carradori","year":"2015","unstructured":"Carradori S, Silvestri R (2015) New frontiers in selective human MAO-B inhibitors. J Med Chem 58:6717\u20136732","journal-title":"J Med Chem"},{"key":"4342_CR14","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.neubiorev.2012.07.011","volume":"36","author":"C Cottingham","year":"2012","unstructured":"Cottingham C, Wang Q (2012) \u03b12-Adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy. Neurosci Biobehav Rev 36:2214\u20132225","journal-title":"Neurosci Biobehav Rev"},{"key":"4342_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2012.02.135","volume":"420","author":"C Cottingham","year":"2012","unstructured":"Cottingham C, Jones A, Wang Q (2012) Desipramine selectively potentiates norepinephrine-elicited ERK1\/2 activation through the \u03b12-adrenergic receptor. Biochem Biophys Res Comm 420:161\u2013165","journal-title":"Biochem Biophys Res Comm"},{"key":"4342_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","volume":"73","author":"MJ Detke","year":"1996","unstructured":"Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43\u201346","journal-title":"Behav Brain Res"},{"key":"4342_CR17","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran DN, Reddy EP (2008) JNK signaling in apoptosis. Oncogene 27:6245\u20136251","journal-title":"Oncogene"},{"key":"4342_CR18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.brainresbull.2009.03.009","volume":"79","author":"\u0141R Drzyzga","year":"2009","unstructured":"Drzyzga \u0141R, Marcinowska A, Obuchowicz E (2009) Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies. Brain Res Bull 79:248\u2013257","journal-title":"Brain Res Bull"},{"key":"4342_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2014.10.028","volume":"225","author":"A Dutta","year":"2015","unstructured":"Dutta A, McKie S, Deakin JF (2015) Ketamine and other potential glutamate antidepressants. Psychiatry Res 225:1\u201313","journal-title":"Psychiatry Res"},{"key":"4342_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002109900045","volume":"360","author":"S Esteban","year":"1999","unstructured":"Esteban S, Llad\u00f3 J, Sastre-Coll A, Garc\u00eda-Sevilla JA (1999) Activation and desensitization by cyclic antidepressant drugs of \u03b12-autoreceptors, \u03b12-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 360:135\u2013143","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"4342_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","volume":"143","author":"JPM Finberg","year":"2014","unstructured":"Finberg JPM (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther 143:133\u2013152","journal-title":"Pharmacol Ther"},{"key":"4342_CR22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","volume":"59","author":"KB Fink","year":"2007","unstructured":"Fink KB, G\u00f6thert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59:360\u2013417","journal-title":"Pharmacol Rev"},{"key":"4342_CR23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuron.2014.01.027","volume":"81","author":"J Flint","year":"2014","unstructured":"Flint J, Kendler KS (2014) The genetics of major depression. Neuron 81:484\u2013503","journal-title":"Neuron"},{"key":"4342_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrn2665","volume":"10","author":"L Galluzzi","year":"2009","unstructured":"Galluzzi L, Blomgren K, Kroemer G (2009) Mitochondrial membrane permeabilization in neuronal injury. Nature Rev Neurosci 10:481\u2013494","journal-title":"Nature Rev Neurosci"},{"key":"4342_CR25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2014.09.018","volume":"89","author":"MJ Garc\u00eda-Fuster","year":"2015","unstructured":"Garc\u00eda-Fuster MJ, Garc\u00eda-Sevilla JA (2015) Monoamine receptor agonists, acting preferentially at presynaptic autoreceptors and heteroreceptors, downregulate the cell fate adaptor FADD in rat brain cortex. Neuropharmacology 89:204\u2013214","journal-title":"Neuropharmacology"},{"key":"4342_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.npp.1301040","volume":"32","author":"MJ Garc\u00eda-Fuster","year":"2007","unstructured":"Garc\u00eda-Fuster MJ, Miralles A, Garc\u00eda-Sevilla JA (2007) Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1\/2 MAP kinase pathway. Neuropsychopharmacology 32:399\u2013411","journal-title":"Neuropsychopharmacology"},{"key":"4342_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroscience.2008.09.002","volume":"157","author":"MJ Garc\u00eda-Fuster","year":"2008","unstructured":"Garc\u00eda-Fuster MJ, Ramos-Miguel A, Rivero G, La Harpe R, Meana JJ, Garc\u00eda-Sevilla JA (2008a) Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers. Neuroscience 157:105\u2013119","journal-title":"Neuroscience"},{"key":"4342_CR28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuropharm.2008.06.071","volume":"55","author":"MJ Garc\u00eda-Fuster","year":"2008","unstructured":"Garc\u00eda-Fuster MJ, Ramos-Miguel A, Miralles A, Garc\u00eda-Sevilla JA (2008b) Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galphai proteins, and ERK1\/2 signaling. Neuropharmacology 55:886\u20138991","journal-title":"Neuropharmacology"},{"key":"4342_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.euroneuro.2011.12.001","volume":"22","author":"MJ Garc\u00eda-Fuster","year":"2012","unstructured":"Garc\u00eda-Fuster MJ, Parks GS, Clinton SM, Watson SJ, Akil H, Civelli O (2012) The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior. Eur Neuropsychopharmacol 22:607\u2013613","journal-title":"Eur Neuropsychopharmacol"},{"key":"4342_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2014.07.027","volume":"277","author":"MJ Garc\u00eda-Fuster","year":"2014","unstructured":"Garc\u00eda-Fuster MJ, D\u00edez-Alarcia R, Ferrer-Alc\u00f3n M, La Harpe R, Meana JJ, Garc\u00eda-Sevilla JA (2014) FADD adaptor and PEA-15\/ERK1\/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments. Neuroscience 277:541\u2013551","journal-title":"Neuroscience"},{"key":"4342_CR31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.npp.1300356","volume":"29","author":"JA Garc\u00eda-Sevilla","year":"2004","unstructured":"Garc\u00eda-Sevilla JA, Ventayol P, P\u00e9rez V, Rubovszky G, Puigdemont D, Ferrer-Alc\u00f3n M et al (2004) Regulation of platelet \u03b12A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology 29:580\u2013588","journal-title":"Neuropsychopharmacology"},{"key":"4342_CR32","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1073\/pnas.0703615105","volume":"105","author":"MM Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez MM, Aston-Jones G (2008) Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats. Proc Natl Acad Sci U S A 105:4898\u20134903","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4342_CR33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.mp.4001067","volume":"7","author":"J Gonz\u00e1lez-Maeso","year":"2002","unstructured":"Gonz\u00e1lez-Maeso J, Rodr\u00edguez-Puertas R, Meana JJ, Garc\u00eda-Sevilla JA, Guim\u00f3n J (2002) Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of \u03b12A-adrenoceptors. Mol Psychiatry 7:755\u2013767","journal-title":"Mol Psychiatry"},{"key":"4342_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pharmthera.2014.03.006","volume":"143","author":"FH Greig","year":"2014","unstructured":"Greig FH, Nixon GF (2014) Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther 143:265\u2013274","journal-title":"Pharmacol Ther"},{"key":"4342_CR35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.nicl.2013.08.016","volume":"3","author":"SM Grieve","year":"2013","unstructured":"Grieve SM, Korgaonkar MS, Koslow SH, Gordon E, Williams LM (2013) Widespread reductions in gray matter volume in depression. Neuroimage Clin 3:332\u2013339","journal-title":"Neuroimage Clin"},{"key":"4342_CR36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.mp.4001755","volume":"11","author":"J Harlan","year":"2006","unstructured":"Harlan J, Chen Y, Gubbins E, Mueller R, Roch JM, Walter K et al (2006) Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol Psychiatry 11:76\u201385","journal-title":"Mol Psychiatry"},{"key":"4342_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","volume":"180","author":"Y Hayasaka","year":"2015","unstructured":"Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A et al (2015) Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 180:179\u2013184","journal-title":"J Affect Disord"},{"key":"4342_CR38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mp.2015.53","volume":"21","author":"F Hieronymus","year":"2016","unstructured":"Hieronymus F, Emilsson JF, Nilsson S, Eriksson E (2016) Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry\u00a021:523\u2013530","journal-title":"Mol Psychiatry"},{"key":"4342_CR39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(91)90177-R","volume":"209","author":"S Hjorth","year":"1991","unstructured":"Hjorth S, Tao R (1991) The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur J Pharmacol 209:249\u2013252","journal-title":"Eur J Pharmacol"},{"key":"4342_CR40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5483\/BMBRep.2014.47.9.239","volume":"47","author":"EY Hwang","year":"2014","unstructured":"Hwang EY, Jeong MS, Park SY, Jang SB (2014) Evidence of complex formation between FADD and c-FLIP death effector domains for the death inducing signaling complex. BMB Rep 47:488\u2013493","journal-title":"BMB Rep"},{"key":"4342_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-008-1126-7","volume":"198","author":"A Jama","year":"2008","unstructured":"Jama A, Cecchi M, Calvo N, Watson SJ, Akil H (2008) Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test. Psychopharmacology (Berl) 198:333\u2013340","journal-title":"Psychopharmacology (Berl)"},{"key":"4342_CR42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12640-013-9430-3","volume":"25","author":"D Jantas","year":"2014","unstructured":"Jantas D, Krawczyk S, Lason W (2014) The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: the effect blocked by inhibitors of MAPK\/ERK1\/2 and PI3-K\/Akt pathways. Neurotox Res 25:208\u2013225","journal-title":"Neurotox Res"},{"key":"4342_CR43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2009.04.053","volume":"1281","author":"Y Jin","year":"2009","unstructured":"Jin Y, Lim CM, Kim SW, Park JY, Seo JS, Han PL et al (2009) Fluoxetine attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Brain Res 1281:108\u2013116","journal-title":"Brain Res"},{"key":"4342_CR44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1615\/CritRevImmunol.v25.i1.30","volume":"25","author":"T Kataoka","year":"2005","unstructured":"Kataoka T (2005) The caspase-8 modulator c-FLIP. Crit Rev Immunol 25:31\u201358","journal-title":"Crit Rev Immunol"},{"key":"4342_CR45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, J\u00f8rgensen TN, S\u00f8rensen L, Eriksen J, Loland CJ et al (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585\u2013640","journal-title":"Pharmacol Rev"},{"key":"4342_CR46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","volume":"379","author":"DJ Kupfer","year":"2012","unstructured":"Kupfer DJ, Frank E, Phillips ML (2012) Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379:1045\u20131055","journal-title":"Lancet"},{"key":"4342_CR47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tips.2015.02.006","volume":"36","author":"SZ Langer","year":"2015","unstructured":"Langer SZ (2015) \u03b12-Adrenoceptors in the treatment of major neuropsychiatric disorders. Trends Pharmacol Sci 36:196\u2013202","journal-title":"Trends Pharmacol Sci"},{"key":"4342_CR48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.euroneuro.2014.12.003","volume":"25","author":"TP Lillethorup","year":"2015","unstructured":"Lillethorup TP, Iversen P, Fontain J, Wegener G, Doudet DJ, Landau AM (2015) Electroconvulsive shocks decrease \u03b12-adrenoceptor binding in the Flinders rat model of depression. Eur Neuropsychopharmacol 25:404\u2013412","journal-title":"Eur Neuropsychopharmacol"},{"key":"4342_CR49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.biopsych.2003.12.014","volume":"55","author":"PJ Lucassen","year":"2004","unstructured":"Lucassen PJ, Fuchs E, Cz\u00e9h B (2004) Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55:789\u2013796","journal-title":"Biol Psychiatry"},{"key":"4342_CR50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pneurobio.2009.04.006","volume":"88","author":"DP McKernan","year":"2009","unstructured":"McKernan DP, Dinan TG, Cryan JF (2009) \u201cKilling the blues\u201d: a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol 88:246\u2013263","journal-title":"Prog Neurobiol"},{"key":"4342_CR51","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/0006-2952(92)90331-C","volume":"43","author":"DJ McManus","year":"1992","unstructured":"McManus DJ, Baker GB, Martin IL, Greenshaw AJ, McKenna KF (1992) Effects of the antidepressant\/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochem Pharmacol 43:2486\u20132489","journal-title":"Biochem Pharmacol"},{"key":"4342_CR52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0006-3223(92)90259-3","volume":"31","author":"JJ Meana","year":"1992","unstructured":"Meana JJ, Barturen F, Garc\u00eda-Sevilla JA (1992) Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry 31:471\u2013490","journal-title":"Biol Psychiatry"},{"key":"4342_CR53","first-page":"101","volume":"341","author":"A Menargues","year":"1990","unstructured":"Menargues A, Obach R, Garc\u00eda-Sevilla JA (1990) Modulation by antidepressant drugs of CNS postsynaptic \u03b12-adrenoceptors mediating mydriasis in the rat. Naunyn Schmiedeberg's Arch Pharmacol 341:101\u2013107","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4342_CR54","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","volume":"63","author":"JH Meyer","year":"2006","unstructured":"Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A et al (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63:1209\u20131216","journal-title":"Arch Gen Psychiatry"},{"key":"4342_CR55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2014.02.010","volume":"158","author":"JJ Miguel-Hidalgo","year":"2014","unstructured":"Miguel-Hidalgo JJ, Whittom A, Villarreal A, Soni M, Meshram A, Pickett JC et al (2014) Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder. J Affect Disord 158:62\u201370","journal-title":"J Affect Disord"},{"key":"4342_CR56","doi-asserted-by":"crossref","unstructured":"Nutt DJ (2002) The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psycopharmacol 17, Suppl. 1, S1\u2013S12","DOI":"10.1097\/00004850-200206001-00002"},{"key":"4342_CR57","first-page":"397","volume":"15","author":"JM O\u2019Donnell","year":"2011","unstructured":"O\u2019Donnell JM, Shelton RC (2011) Drug therapy of depression and anxiety disorders. In Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics, 12th edition (Editor, L.L. Brunton). New York, McGraw Hill Medical. Chapter 15:397\u2013415","journal-title":"Chapter"},{"key":"4342_CR58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-4159.1969.tb08978.x","volume":"16","author":"N Popov","year":"1969","unstructured":"Popov N, Matthies H (1969) Some effects of monoamine oxidase inhibitors on the metabolism of gamma-aminobutyric acid in rat brain. J Neurochem 16:899\u2013907","journal-title":"J Neurochem"},{"key":"4342_CR59","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","volume":"45","author":"G Rajkowska","year":"1999","unstructured":"Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45:1085\u20131098","journal-title":"Biol Psychiatry"},{"key":"4342_CR60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2009.03.028","volume":"161","author":"A Ramos-Miguel","year":"2009","unstructured":"Ramos-Miguel A, Garc\u00eda-Fuster MJ, Callado LF, La Harpe R, Meana JJ, Garc\u00eda-Sevilla JA (2009) Phosphorylation of FADD at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15\u00a0kDa, and Akt signaling pathways involved in neuroplasticity. Neuroscience 161:23\u201338","journal-title":"Neuroscience"},{"key":"4342_CR61","doi-asserted-by":"crossref","unstructured":"Ramos-Miguel A, \u00c1lvaro-Bartolom\u00e9 M, Garc\u00eda-Fuster MJ, Garc\u00eda-Sevilla JA (2012) Role of multifunctional FADD (Fas-associated death domain) adaptor in drug addiction (Chapter 7). In: Addictions\u2014From Pathophysiology to Treatment. In InTech Open. Edited by David Belin. ISBN: 978-953-51-0783-5","DOI":"10.5772\/34273"},{"key":"4342_CR62","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/BJ20050378","volume":"390","author":"H Renganathan","year":"2005","unstructured":"Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW (2005) Phosphorylation of PEA-15 switches its binding specificity from ERK\/MAPK to FADD. Biochem J 390:729\u2013735","journal-title":"Biochem J"},{"key":"4342_CR63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2014.06.016","volume":"167","author":"G Rivero","year":"2014","unstructured":"Rivero G, Gabilondo AM, Garc\u00eda-Sevilla JA, La Harpe R, Callado LF, Meana JJ (2014) Increased \u03b12- and \u03b21-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment. J Affect Disord 167:343\u2013350","journal-title":"J Affect Disord"},{"key":"4342_CR64","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1073\/pnas.0431215100","volume":"100","author":"RA Screaton","year":"2003","unstructured":"Screaton RA, Kiessling S, Sansom OJ, Millar CB, Maddison K, Bird A et al (2003) Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci U S A 100:5211\u20135216","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4342_CR65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","volume":"22","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197\u2013217","journal-title":"Annu Rev Neurosci"},{"key":"4342_CR66","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1017\/S1461145713000436","volume":"16","author":"E Sibille","year":"2013","unstructured":"Sibille E, French B (2013) Biological substrates underpinning diagnosis of major depression. Int J Neuropsychopharmacol 16:1893\u20131909","journal-title":"Int J Neuropsychopharmacol"},{"key":"4342_CR67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1471-4159.2001.00484.x","volume":"78","author":"K Starke","year":"2001","unstructured":"Starke K (2001) Presynaptic autoreceptors in the third decade: focus on \u03b12-adrenoceptors. J Neurochem 78:685\u2013693","journal-title":"J Neurochem"},{"key":"4342_CR68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/JCP.0407e10","volume":"68","author":"JW Stewart","year":"2007","unstructured":"Stewart JW (2007) Treating depression with atypical features. J Clin Psychiatry 68:25\u201329","journal-title":"J Clin Psychiatry"},{"key":"4342_CR69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/sgtp.20021","volume":"3","author":"F Sulzmaier","year":"2012","unstructured":"Sulzmaier F, Opoku-Ansah J, Ramos JW (2012) Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases 3:173\u2013177","journal-title":"Small GTPases"},{"key":"4342_CR70","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/cdd.2014.237","volume":"22","author":"DC Tanner","year":"2015","unstructured":"Tanner DC, Campbell A, O'Banion KM, Noble M, Mayer-Pr\u00f6schel M (2015) cFLIP is critical for oligodendrocyte protection from inflammation. Cell Death Differ\u00a022:1489\u20131501","journal-title":"Cell Death Differ"},{"key":"4342_CR71","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1523\/JNEUROSCI.1091-07.2007","volume":"27","author":"E Taoufik","year":"2007","unstructured":"Taoufik E, Valable S, M\u00fcller GJ, Roberts ML, Divoux D, Tinel A et al (2007) FLIPL protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J Neurosci 27:6633\u20136646","journal-title":"J Neurosci"},{"key":"4342_CR72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1476-5381.1992.tb14351.x","volume":"106","author":"DN Thomas","year":"1992","unstructured":"Thomas DN, Nutt DJ, Holman RB (1992) Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmacol 106:430\u2013434","journal-title":"Br J Pharmacol"},{"key":"4342_CR73","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/MCB.23.13.4511-4521.2003","volume":"23","author":"A Trencia","year":"2003","unstructured":"Trencia A, Perfetti A, Cassese A, Vigliotta G, Miele C, Oriente F et al (2003) Protein kinase B\/Akt binds and phosphorylates PED\/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol 23:4511\u20134521","journal-title":"Mol Cell Biol"},{"key":"4342_CR74","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1601-183X.2008.00402.x","volume":"7","author":"L Urig\u00fcen","year":"2008","unstructured":"Urig\u00fcen L, Arteta D, D\u00edez-Alarcia R, Ferrer-Alc\u00f3n M, D\u00edaz A, Pazos A et al (2008) Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav 7:649\u2013658","journal-title":"Genes Brain Behav"},{"key":"4342_CR75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2014.08.024","volume":"89","author":"V Waes Van","year":"2015","unstructured":"Van Waes V, Ehrlich S, Beverley JA, Steiner H (2015) Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor. Neuropharmacology 89:77\u201386","journal-title":"Neuropharmacology"},{"key":"4342_CR76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pnpbp.2015.03.014","volume":"64","author":"E Won","year":"2016","unstructured":"Won E, Ham B-J (2016) Imaging genetics studies on monoaminergic genes in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 64:311\u2013319","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4342_CR77","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/j.1460-9568.2012.08187.x","volume":"36","author":"D Yang","year":"2012","unstructured":"Yang D, Chen M, Russo-Neustadt A (2012) Antidepressants are neuroprotective against nutrient deprivation stress in rat hippocampal neurons. Eur J Neurosci 36:2573\u20132587","journal-title":"Eur J Neurosci"},{"key":"4342_CR78","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1017\/S0033291714000518","volume":"44","author":"Y-J Zhao","year":"2014","unstructured":"Zhao Y-J, Du M-Y, Huang X-Q, Lui S, Chen Z-Q, Liu J et al (2014) Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis. Psychol Med 44:2927\u20132937","journal-title":"Psychol Med"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4342-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4342-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4342-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:40:32Z","timestamp":1498304432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4342-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,3]]},"references-count":78,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4342"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4342-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,3]]}}}